Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
47.32
-1.61 (-3.29%)
At close: Jul 2, 2024, 4:00 PM
47.90
+0.58 (1.23%)
After-hours: Jul 2, 2024, 7:38 PM EDT

Twist Bioscience Income Statement

Millions USD. Fiscal year is Oct - Sep.
Year
20232022202120202019 2018 - 2016
Revenue
245.11203.57132.3390.154.39
Upgrade
Revenue Growth (YoY)
20.41%53.83%46.87%65.67%113.89%
Upgrade
Cost of Revenue
155.38119.3380.6261.4147.43
Upgrade
Gross Profit
89.7384.2451.7128.696.96
Upgrade
Selling, General & Admin
189.74212.95135.9103.2780.13
Upgrade
Research & Development
106.89120.3169.0743.0135.68
Upgrade
Other Operating Expenses
10.26-14.25-0.5322.50
Upgrade
Operating Expenses
306.89319.01204.44168.77115.81
Upgrade
Operating Income
-217.16-234.78-152.73-140.08-108.85
Upgrade
Interest Expense / Income
0.010.080.370.791.29
Upgrade
Other Expense / Income
-13.7-6.580.94-1.32-2.77
Upgrade
Pretax Income
-203.47-228.27-154.03-139.55-107.38
Upgrade
Income Tax
1.15-10.41-1.930.380.29
Upgrade
Net Income
-204.62-217.86-152.1-139.93-107.67
Upgrade
Shares Outstanding (Basic)
5754483927
Upgrade
Shares Outstanding (Diluted)
5754483927
Upgrade
Shares Change
5.57%11.68%23.12%42.71%883.24%
Upgrade
EPS (Basic)
-3.60-4.04-3.15-3.57-3.92
Upgrade
EPS (Diluted)
-3.60-4.04-3.15-3.57-3.92
Upgrade
Free Cash Flow
-170.25-226.24-139.31-152.12-102.67
Upgrade
Free Cash Flow Per Share
-2.99-4.20-2.89-3.88-3.74
Upgrade
Gross Margin
36.61%41.38%39.08%31.85%12.80%
Upgrade
Operating Margin
-88.60%-115.33%-115.41%-155.47%-200.15%
Upgrade
Profit Margin
-83.48%-107.02%-114.94%-155.31%-197.98%
Upgrade
Free Cash Flow Margin
-69.46%-111.14%-105.27%-168.84%-188.79%
Upgrade
EBITDA
-171.58-191.55-141.67-133.13-99.97
Upgrade
EBITDA Margin
-70.00%-94.10%-107.05%-147.76%-183.82%
Upgrade
Depreciation & Amortization
31.8836.6411.995.636.11
Upgrade
EBIT
-203.46-228.19-153.66-138.76-106.08
Upgrade
EBIT Margin
-83.01%-112.10%-116.12%-154.01%-195.06%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).